Literature DB >> 21951573

Changes in the levels of factor VIII and von Willebrand factor in the puerperium.

F Y Huq1, A Kulkarni, E C Agbim, A Riddell, E Tuddenham, R A Kadir.   

Abstract

To determine changes in Factor VIII (FVIII) and von Willebrand Factor (VWF) in the first 3 days of the puerperium. A prospective study assessing FVIII clotting activity, VWF activity and antigen levels in 95 women (with singleton uncomplicated pregnancies) during labour and on days 1, 2 and 3 of the puerperium. There were no significant differences in FVIII, VWF:Ag and VWF:CB on days 1 and 2 of the puerperium compared with levels during labour. There was a significant decrease in VWF:Ag (P = 0.009) and VWF:CB (P = 0.04) on day 3. Age, ethnicity, duration of labour and mode of delivery did not have any significant effect on the changes in FVIII and VWF levels. The pregnancy induced increase in FVIII and VWF is maintained in the first 48 h after delivery. VWF levels start to decline on day 3 postdelivery.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21951573     DOI: 10.1111/j.1365-2516.2011.02625.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  5 in total

1.  Antifibrinolytic therapy for preventing VWD-related postpartum hemorrhage: indications and limitations.

Authors:  Peter A Kouides
Journal:  Blood Adv       Date:  2017-04-25

2.  Blood volume-based von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease.

Authors:  Margaret V Ragni
Journal:  Blood Adv       Date:  2017-04-25

Review 3.  Pregnancy in special populations: challenges and solutions practical aspects of managing von Willebrand disease in pregnancy.

Authors:  Ozlem Turan; Rezan Abdul Kadir
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 4.  Current and Emerging Options for the Management of Inherited von Willebrand Disease.

Authors:  Jessica M Heijdra; Marjon H Cnossen; Frank W G Leebeek
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

Review 5.  Managing Pregnant Women with Hemophilia and von Willebrand Disease: How Do We Provide Optimum Care and Prevent Complications?

Authors:  Maissaa Janbain; Peter Kouides
Journal:  Int J Womens Health       Date:  2022-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.